Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its Global Phase 3 MRCT 2023-04-14 19:00
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults 2023-04-14 01:15
Viva Biotech Attended SAPA-China 2023-04-13 11:33
Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis 2023-04-13 06:00
Standigm announces Younsung Choo as chief executive officer 2023-04-13 00:07
GC Genome-KAIST team Announces Publication of a Groundbreaking AI-Based Liquid Biopsy Technology for Multi-Cancer Early Detection and Localization in Nature Communications 2023-04-12 11:06
Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia 2023-04-12 06:00
OnCusp Therapeutics Showcases Potent Anti-Tumor Activity of its CDH6 ADC at AACR Annual Meeting 2023 2023-04-11 20:00
Asieris' subsidiary makes significant progress in its commercialization strategy by obtaining the "Drug Distribution License" 2023-04-10 20:18
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released 2023-04-07 16:34
Nuance Pharma Announces Dosing of First Patient in ENHANCE - China Phase III Trial for Chronic Obstructive Pulmonary Disease ("COPD") 2023-04-07 10:00
BIORCHESTRA Expands Executive Leadership Team with the Appointment of David Oxley as Chief Business Officer 2023-04-05 20:00
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis 2023-04-04 20:50
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects 2023-04-04 20:00
GC Cell and New Management Embarking on a New Chapter 2023-04-03 16:47
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
The World's Second Approved Biosimilars of Denosumab (MAILISHU) 2023-04-03 13:44
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner 2023-04-01 10:00
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 2023-03-31 18:30
Boao Forum for Asia Enters the Healthcare Sector 2023-03-31 10:00
1 53 54 55 56 57 165